Tag
NYSE: QGEN
Tempus AI wins FDA clearance for fourth ECG tool targeting mitral regurgitation
Adrian Kessler · Sep 29, 2026
QIAGEN says FDA cleared second QIAstat‑Dx bloodstream panel
Adrian Kessler · Sep 28, 2026